ダーマフィラーの世界市場 (～2030年)：ブランド (Juvederm・Sculptra・Radiesse)・製品 (ヒアルロン酸・コラーゲン・PLLA)・施術 (皮膚の若返り・傷跡除去・顔&身体の輪郭形成)・エンドユーザー (皮膚科クリニック・美容センター・メディカルスパ) 別

ダーマフィラーの市場は大幅な成長が見込まれ、市場規模は2025年の41億米ドルから、2030年には73億米ドルに増加すると予測されています。

この市場の成長は、低侵襲の美容施術に対する需要など、さまざまな要因によって促進されています。ソーシャルメディアの動向は、特にミレニアル世代やZ世代の間で、フィラーの使用を一般化・神話化しており、シワやボリュームの喪失など加齢による皮膚の問題の広がりも、美容施術への需要を後押ししています。

また、フェイスライン、あご、手など、新たな用途でのフィラー使用が増えており、個別化された施術への需要も高まっています。

さらに、継続的な研究開発と改良された製剤 (例えば、生分解性で長持ちする注入剤) や注入技術によって、フィラーの長期的な安全性が保証され、施術者や患者にとって一層魅力的な選択肢となっています。これらの動向は今後も世界市場の成長を促進し続けるでしょう。

"2024年は天然ダーマフィラーが市場を独占"

特にヒアルロン酸、コラーゲン、その他の生分解性・生体適合性材料に基づく天然ダーマフィラーが市場をリードしています。これらは生体適合性が高く、アレルギー反応や副作用のリスクが低いうえ、可逆的であることが理由です。また、美容向けの改善を目的とした低侵襲処置への世界的な関心の高まりが成長を後押ししており、天然ダーマフィラーは手術を伴わない代替手段として、顔の若返り、シワの補正、ボリューム回復に利用されています。消費者主導のこの動きでは、安全性、生体適合性、自然な仕上がりが重視されており、ヒアルロン酸などの生分解性のフィラーが特に支持されています。これらの天然ダーマフィラーは、ミレニアル世代やZ世代の嗜好、SNSや若年層文化の影響とも相まって、市場における主流製品であり続けています。

"アジア太平洋地域は予測期間中に最も高いCAGRを記録する見込み"

この成長は、人口動態、経済、文化、技術といった多様な要素が複合的に作用することで促進されています。特に、若年層や中年層を中心とした美容施術に対する認知と受容の拡大といった人口動態の変化や、経済成長に伴う中間層の拡大によって可処分所得が増加し、非侵襲的な美容皮膚治療へのアクセスがより多くの人々に可能となったことが、大きな要因となっています。また、安全性・有効性・持続性が大幅に向上した次世代フィラーの研究開発や製品の上市も、市場成長を後押ししています。さらに、美容意識の高まりやソーシャルメディアの影響、持続的な経済成長、高齢化の進行、革新的技術の継続的導入、医療観光の発展、政府の支援的な政策、医療インフラの整備といったさまざまな要因が市場の加速要因として機能しています。このように、アジア太平洋のダーマフィラー市場は、イノベーションを原動力とした大規模かつ極めて競争力の高い市場として、絶えず急速な成長を遂げています。

当レポートでは、世界のダーマフィラーの市場を調査し、市場概要、市場成長への各種影響因子の分析、技術・特許の動向、法規制環境、ケーススタディ、市場規模の推移・予測、各種区分・地域/主要国別の詳細分析、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

• 市場力学
  • 促進要因
  • 抑制要因
  • 機会
  • 課題
• 顧客の事業に影響を与える動向/混乱
• 価格分析
• バリューチェーン分析
• サプライチェーン分析
• エコシステム分析
• 投資と資金調達のシナリオ
• 技術分析
• 特許分析
• 貿易分析
• 2025-2026年の主な会議とイベント
• ケーススタディ分析
• 規制状況
• ポーターのファイブフォース分析
• 主要な利害関係者と購入基準
• 償還シナリオ
• アンメットニーズと主な問題点
• AIがダーマフィラー市場に与える影響
• 米国関税

第6章 ダーマフィラー市場：ブランド別

• JUVEDERM
• RESTYLANE
• RHA COLLECTION
• SCULPTRA
• RADIESSE
• LANLUMA
• BELLAFILL
• その他

第7章 ダーマフィラー市場：製品タイプ別

• 天然ダーマフィラー
  • ヒアルロン酸フィラー
  • コラーゲンフィラー
• 合成フィラー
  • カルシウムヒドロキシアパタイト (CAHA) フィラー
  • ポリL-乳酸 (PLLA) フィラー
  • ポリメチルメタクリレート (PMMA) フィラー
  • ポリヌクレオチドフィラー
  • その他の合成フィラー

第8章 ダーマフィラー市場：施術別

• 皮膚の若返り
• 顔&身体の輪郭形成
• 唇の増大
• その他

第9章 フィラー市場：エンドユーザー別

• 皮膚科クリニック・病院
• 美容センター
• メディカルスパ
• その他

第10章 ダーマフィラー市場：地域別

• 北米
  • 北米のマクロ経済見通し
  • 米国
  • カナダ
• 欧州
  • 欧州のマクロ経済見通し
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他
• アジア太平洋
  • アジア太平洋地域のマクロ経済見通し
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • その他
• ラテンアメリカ
  • ラテンアメリカのマクロ経済見通し
  • ブラジル
  • メキシコ
  • その他
• 中東・アフリカ
  • 中東・アフリカのマクロ経済見通し
  • GCC諸国
  • その他

第11章 競合情勢

• 主要参入企業の戦略/強み
• 収益分析
• 市場シェア分析
• 企業評価と財務指標
• ブランド/製品比較
• 企業評価マトリックス：主要企業
• 企業評価マトリックス：スタートアップ/中小企業
• 競合シナリオ

第12章 企業プロファイル

• 主要企業
  • ABBVIE INC.
  • GALDERMA
  • MERZ PHARMA
  • SILCLAIR PHARMA
  • REVANCE
  • CROMA PHARMA
  • EVOLUS, INC.
  • HUGEL, INC.
  • MEDYTOX
  • BIOXIS PHARMACEUTICAL
  • ZIMMER MEDIZINSYSTEME GMBH
  • CUTERA, INC.
  • SCIVISION BIOTECH INC.
  • BRIDGEPOINT GROUP PLC
  • ANIKA THERAPEUTICS, INC.
• その他の企業
  • TIGER AESTHETICS MEDICAL
  • PROLLENIUM MEDICAL TECHNOLOGIES
  • BIOSCIENCE GMBH
  • DERMAX
  • TEOXANE
  • DR. KORMAN LABORATORIES LTD.
  • CYTOPHIL, INC.
  • TELETA PHARMA
  • IBSA DERMA
  • NEOGENESIS
  • CGBIO, CO., LTD.

第13章 付録

List of Tables

• TABLE 1 DERMA FILLERS MARKET: INCLUSIONS AND EXCLUSIONS
• TABLE 2 STANDARD CURRENCY CONVERSION RATES, 2021-2023
• TABLE 3 DERMA FILLERS MARKET: RISK ANALYSIS
• TABLE 4 AVERAGE SELLING PRICE TREND OF HYALURONIC ACID FILLERS, BY KEY PLAYER, 2022-2024 (USD)
• TABLE 5 AVERAGE SELLING PRICE TREND OF DERMA FILLER PRODUCTS, BY REGION, 2022-2024 (USD)
• TABLE 6 DERMA FILLERS MARKET: ROLE OF COMPANIES IN ECOSYSTEM
• TABLE 7 DERMA FILLERS MARKET: INNOVATIONS AND PATENT REGISTRATIONS, 2022-2024
• TABLE 8 IMPORT DATA FOR HS CODE 330499, BY COUNTRY, 2020-2024 (USD THOUSAND)
• TABLE 9 EXPORT DATA FOR HS CODE 611510, BY COUNTRY, 2020-2024 (USD THOUSAND)
• TABLE 10 DERMA FILLERS MARKET: KEY CONFERENCES AND EVENTS, 2025-2026
• TABLE 11 US FDA: MEDICAL DEVICE CLASSIFICATION
• TABLE 12 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 13 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 14 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 15 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 16 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 17 DERMA FILLERS MARKET: PORTER'S FIVE FORCES ANALYSIS
• TABLE 18 KEY REQUIREMENTS OF STAKEHOLDERS WHILE BUYING DERMA FILLERS
• TABLE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF DERMA FILLERS, BY PRODUCT TYPE (%)
• TABLE 20 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER
• TABLE 21 REIMBURSEMENT CODES FOR VARIOUS PROCEDURES
• TABLE 22 UNMET CUSTOMER NEEDS AND KEY PAIN POINTS
• TABLE 23 US ADJUSTED RECIPROCAL TARIFF RATES
• TABLE 24 DERMA FILLERS MARKET, BY BRAND, 2023-2030 (USD MILLION)
• TABLE 25 DERMA FILLERS MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
• TABLE 26 NATURAL DERMAL FILLERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 27 NORTH AMERICA: NATURAL DERMAL FILLERS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 28 EUROPE: NATURAL DERMAL FILLERS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 29 ASIA PACIFIC: NATURAL DERMAL FILLERS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 30 LATIN AMERICA: NATURAL DERMAL FILLERS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 31 MIDDLE EAST & AFRICA: NATURAL DERMAL FILLERS MARKET, BY REGION, 2023-2030 (USD MILLION)
• TABLE 32 NATURAL DERMAL FILLERS MARKET, BY PROCEDURE, 2023-2030 (USD MILLION)
• TABLE 33 NATURAL DERMAL FILLERS MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 34 HYALURONIC ACID FILLERS MARKET, BY REGION, 2023-2030 (USD MILLION)
• TABLE 35 COLLAGEN FILLERS MARKET, BY REGION, 2023-2030 (USD MILLION)
• TABLE 36 SYNTHETIC DERMAL FILLERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 37 NORTH AMERICA: SYNTHETIC DERMAL FILLERS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 38 EUROPE: SYNTHETIC DERMAL FILLERS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 39 ASIA PACIFIC: SYNTHETIC DERMAL FILLERS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 40 LATIN AMERICA: SYNTHETIC DERMAL FILLERS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 41 MIDDLE EAST & AFRICA: SYNTHETIC DERMAL FILLERS MARKET, BY REGION, 2023-2030 (USD MILLION)
• TABLE 42 SYNTHETIC DERMAL FILLERS MARKET, BY PROCEDURE, 2023-2030 (USD MILLION)
• TABLE 43 SYNTHETIC DERMAL FILLERS MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 44 CALCIUM HYDROXYLAPATITE (CAHA) FILLERS MARKET, BY REGION, 2023-2030 (USD MILLION)
• TABLE 45 POLY-L-LACTIC ACID (PLLA) FILLERS MARKET, BY REGION, 2023-2030 (USD MILLION)
• TABLE 46 POLYMETHYL METHACRYLATE (PMMA) FILLERS MARKET, BY REGION, 2023-2030 (USD MILLION)
• TABLE 47 POLYNUCLEOTIDE FILLERS MARKET, BY REGION, 2023-2030 (USD MILLION)
• TABLE 48 OTHER SYNTHETIC FILLERS MARKET, BY REGION, 2023-2030 (USD MILLION)
• TABLE 49 DERMA FILLERS MARKET, BY PROCEDURE, 2023-2030 (USD MILLION)
• TABLE 50 DERMA FILLERS MARKET FOR SKIN REJUVENATION, BY REGION, 2023-2030 (USD MILLION)
• TABLE 51 DERMA FILLERS MARKET FOR FACE & BODY CONTOURING, BY REGION, 2023-2030 (USD MILLION)
• TABLE 52 DERMA FILLERS MARKET FOR LIP AUGMENTATION, BY REGION, 2023-2030 (USD MILLION)
• TABLE 53 DERMA FILLERS MARKET FOR OTHER PROCEDURES, BY REGION, 2023-2030 (USD MILLION)
• TABLE 54 DERMA FILLERS MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 55 DERMA FILLERS MARKET FOR DERMATOLOGY CLINICS & HOSPITALS, BY REGION, 2023-2030 (USD MILLION)
• TABLE 56 DERMA FILLERS MARKET FOR BEAUTY CENTERS, BY REGION, 2023-2030 (USD MILLION)
• TABLE 57 DERMA FILLERS MARKET FOR MEDICAL SPAS, BY REGION, 2023-2030 (USD MILLION)
• TABLE 58 DERMA FILLERS MARKET FOR OTHER END USERS, BY REGION, 2023-2030 (USD MILLION)
• TABLE 59 DERMA FILLERS MARKET, BY REGION, 2023-2030 (USD MILLION)
• TABLE 60 GLOBAL DERMA FILLERS PROCEDURE, 2021-2023
• TABLE 61 NORTH AMERICA: MACROECONOMIC OUTLOOK
• TABLE 62 NORTH AMERICA: DERMA FILLERS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 63 NORTH AMERICA: DERMA FILLERS MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
• TABLE 64 NORTH AMERICA: NATURAL DERMAL FILLERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 65 NORTH AMERICA: SYNTHETIC DERMAL FILLERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 66 NORTH AMERICA: DERMA FILLERS MARKET, BY PROCEDURE, 2023-2030 (USD MILLION)
• TABLE 67 NORTH AMERICA: DERMA FILLERS MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 68 US: DERMA FILLER PROCEDURES, 2021-2023
• TABLE 69 US: DERMA FILLERS MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
• TABLE 70 CANADA: DERMA FILLERS MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
• TABLE 71 EUROPE: DERMA FILLERS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 72 EUROPE: DERMA FILLERS MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
• TABLE 73 EUROPE: NATURAL DERMAL FILLERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 74 EUROPE: SYNTHETIC DERMAL FILLERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 75 EUROPE: DERMA FILLERS MARKET, BY PROCEDURE, 2023-2030 (USD MILLION)
• TABLE 76 EUROPE: DERMA FILLERS MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 77 EUROPE: MACROECONOMIC OUTLOOK
• TABLE 78 GERMANY: DERMA FILLER PROCEDURES, 2021-2023
• TABLE 79 GERMANY: DERMA FILLERS MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
• TABLE 80 UK: DERMA FILLER PROCEDURES, 2022-2023
• TABLE 81 UK: DERMA FILLERS MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
• TABLE 82 FRANCE: DERMA FILLER PROCEDURES, 2023
• TABLE 83 FRANCE: DERMA FILLERS MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
• TABLE 84 ITALY: DERMA FILLER PROCEDURES, 2021-2023
• TABLE 85 ITALY: DERMA FILLERS MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
• TABLE 86 SPAIN: DERMA FILLER PROCEDURES, 2021-2023
• TABLE 87 SPAIN: DERMA FILLERS MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
• TABLE 88 REST OF EUROPE: DERMA FILLERS MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
• TABLE 89 ASIA PACIFIC: MACROECONOMIC OUTLOOK
• TABLE 90 ASIA PACIFIC: DERMA FILLERS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 91 ASIA PACIFIC: DERMA FILLERS MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
• TABLE 92 ASIA PACIFIC: NATURAL DERMAL FILLERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 93 ASIA PACIFIC: SYNTHETIC DERMAL FILLERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 94 ASIA PACIFIC: DERMA FILLERS MARKET, BY PROCEDURE, 2023-2030 (USD MILLION)
• TABLE 95 ASIA PACIFIC: DERMA FILLERS MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 96 JAPAN: DERMA FILLERS MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
• TABLE 97 CHINA: DERMA FILLERS MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
• TABLE 98 INDIA: DERMA FILLER PROCEDURES, 2021-2023
• TABLE 99 INDIA: DERMA FILLERS MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
• TABLE 100 AUSTRALIA: DERMA FILLERS MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
• TABLE 101 SOUTH KOREA: DERMA FILLERS MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
• TABLE 102 REST OF ASIA PACIFIC: DERMA FILLERS MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
• TABLE 103 LATIN AMERICA: DERMA FILLERS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 104 LATIN AMERICA: DERMA FILLERS MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
• TABLE 105 LATIN AMERICA: NATURAL DERMAL FILLERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 106 LATIN AMERICA: SYNTHETIC DERMAL FILLERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 107 LATIN AMERICA: DERMA FILLERS MARKET, BY PROCEDURE, 2023-2030 (USD MILLION)
• TABLE 108 LATIN AMERICA: DERMA FILLERS MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 109 LATIN AMERICA: MACROECONOMIC OUTLOOK
• TABLE 110 BRAZIL: DERMA FILLER PROCEDURES, 2021-2023
• TABLE 111 BRAZIL: DERMA FILLERS MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
• TABLE 112 MEXICO: DERMA FILLER PROCEDURES, 2021-2023
• TABLE 113 MEXICO: DERMA FILLERS MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
• TABLE 114 REST OF LATIN AMERICA: DERMA FILLERS MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
• TABLE 115 MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK
• TABLE 116 MIDDLE EAST & AFRICA: DERMA FILLERS MARKET, BY REGION, 2023-2030 (USD MILLION)
• TABLE 117 MIDDLE EAST & AFRICA: DERMA FILLERS MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
• TABLE 118 MIDDLE EAST & AFRICA: NATURAL DERMAL FILLERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 119 MIDDLE EAST & AFRICA: SYNTHETIC DERMAL FILLERS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 120 MIDDLE EAST & AFRICA: DERMA FILLERS MARKET, BY PROCEDURE, 2023-2030 (USD MILLION)
• TABLE 121 MIDDLE EAST & AFRICA: DERMA FILLERS MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 122 GCC COUNTRIES: DERMA FILLERS MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
• TABLE 123 REST OF MIDDLE EAST & AFRICA: DERMA FILLERS MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
• TABLE 124 OVERVIEW OF STRATEGIES DEPLOYED BY KEY COMPANIES IN DERMA FILLERS MARKET, JANUARY 2022-MAY 2025
• TABLE 125 DERMA FILLERS MARKET: DEGREE OF COMPETITION
• TABLE 126 DERMA FILLERS MARKET: REGION FOOTPRINT
• TABLE 127 DERMA FILLERS MARKET: PRODUCT TYPE FOOTPRINT
• TABLE 128 DERMA FILLERS MARKET: PROCEDURE FOOTPRINT
• TABLE 129 DERMA FILLERS MARKET: END-USER FOOTPRINT
• TABLE 130 DERMA FILLERS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
• TABLE 131 DERMA FILLERS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
• TABLE 132 DERMA FILLERS MARKET: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021-MAY 2025
• TABLE 133 DERMA FILLERS MARKET: DEALS, JANUARY 2021-MAY 2025
• TABLE 134 ABBVIE INC.: COMPANY OVERVIEW
• TABLE 135 ABBVIE INC.: PRODUCTS OFFERED
• TABLE 136 ABBVIE INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021-MAY 2025
• TABLE 137 GALDERMA: COMPANY OVERVIEW
• TABLE 138 GALDERMA: PRODUCTS OFFERED
• TABLE 139 GALDERMA: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021-MAY 2025
• TABLE 140 GALDERMA: DEALS, JANUARY 2021-MAY 2025
• TABLE 141 GALDERMA: EXPANSIONS, JANUARY 2021-MAY 2025
• TABLE 142 MERZ PHARMA: COMPANY OVERVIEW
• TABLE 143 MERZ PHARMA: PRODUCTS OFFERED
• TABLE 144 MERZ PHARMA: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021-MAY 2025
• TABLE 145 MERZ PHARMA: EXPANSIONS, JANUARY 2021-MAY 2024
• TABLE 146 SILCLAIR PHARMA: COMPANY OVERVIEW
• TABLE 147 SILCLAIR PHARMA: PRODUCTS OFFERED
• TABLE 148 REVANCE: COMPANY OVERVIEW
• TABLE 149 REVANCE: PRODUCTS OFFERED
• TABLE 150 REVANCE: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021-MAY 2025
• TABLE 151 REVANCE: DEALS, JANUARY 2021-MAY 2025
• TABLE 152 CROMA PHARMA: COMPANY OVERVIEW
• TABLE 153 CROMA PHARMA: PRODUCTS OFFERED
• TABLE 154 EVOLUS, INC.: COMPANY OVERVIEW
• TABLE 155 EVOLUS, INC.: PRODUCTS OFFERED
• TABLE 156 EVOLUS, INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021-MAY 2025
• TABLE 157 HUGEL, INC.: COMPANY OVERVIEW
• TABLE 158 HUGEL, INC.: PRODUCTS OFFERED
• TABLE 159 MEDYTOX: COMPANY OVERVIEW
• TABLE 160 MEDYTOX: PRODUCTS OFFERED
• TABLE 161 BIOXIS PHARMACEUTICAL: COMPANY OVERVIEW
• TABLE 162 BIOXIS PHARMACEUTICAL: PRODUCTS OFFERED
• TABLE 163 ZIMMER MEDIZINSYSTEME GMBH: COMPANY OVERVIEW
• TABLE 164 ZIMMER MEDIZINSYSTEME GMBH: PRODUCTS OFFERED
• TABLE 165 CUTERA, INC.: COMPANY OVERVIEW
• TABLE 166 CUTERA, INC.: PRODUCTS OFFERED
• TABLE 167 CUTERA, INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021-MAY 2025
• TABLE 168 CUTERA, INC.: DEALS, JANUARY 2021-MAY 2025
• TABLE 169 SCIVISION BIOTECH INC.: COMPANY OVERVIEW
• TABLE 170 SCIVISION BIOTECH INC.: PRODUCTS OFFERED
• TABLE 171 BRIDGEPOINT GROUP PLC: COMPANY OVERVIEW
• TABLE 172 BRIDGEPOINT GROUP PLC: PRODUCTS OFFERED
• TABLE 173 ANIKA THERAPEUTICS, INC.: COMPANY OVERVIEW
• TABLE 174 ANIKA THERAPEUTICS, INC.: PRODUCTS OFFERED
• TABLE 175 TIGER AESTHETICS MEDICAL: COMPANY OVERVIEW
• TABLE 176 PROLLENIUM MEDICAL TECHNOLOGIES: COMPANY OVERVIEW
• TABLE 177 BIOSCIENCE GMBH: COMPANY OVERVIEW
• TABLE 178 DERMAX: COMPANY OVERVIEW
• TABLE 179 TEOXANE: COMPANY OVERVIEW
• TABLE 180 DR. KORMAN LABORATORIES LTD.: COMPANY OVERVIEW
• TABLE 181 CYTOPHIL, INC.: COMPANY OVERVIEW
• TABLE 182 TELETA PHARMA: COMPANY OVERVIEW
• TABLE 183 IBSA DERMA: COMPANY OVERVIEW
• TABLE 184 NEOGENESIS: COMPANY OVERVIEW
• TABLE 185 CGBIO, CO., LTD.: COMPANY OVERVIEW

List of Figures

• FIGURE 1 DERMA FILLERS MARKET SEGMENTATION AND REGIONAL SCOPE
• FIGURE 2 DERMA FILLERS MARKET: RESEARCH DESIGN
• FIGURE 3 DERMA FILLERS MARKET: RESEARCH DATA
• FIGURE 4 KEY PRIMARY SOURCES
• FIGURE 5 SUPPLY- AND DEMAND-SIDE PARTICIPANTS
• FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
• FIGURE 7 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
• FIGURE 8 MARKET SIZE ESTIMATION: COMPANY REVENUE ESTIMATION
• FIGURE 9 DERMA FILLERS MARKET SIZE ESTIMATION METHODOLOGY
• FIGURE 10 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
• FIGURE 11 GROWTH RATE PROJECTIONS BASED ON MARKET DRIVERS
• FIGURE 12 GROWTH RATE PROJECTIONS BASED ON MARKET OPPORTUNITIES, RESTRAINTS, AND CHALLENGES
• FIGURE 13 DATA TRIANGULATION
• FIGURE 14 DERMA FILLERS MARKET, BY BRAND, 2025 VS. 2030
• FIGURE 15 DERMA FILLERS MARKET, BY PRODUCT TYPE, 2025 VS. 2030 (USD MILLION)
• FIGURE 16 DERMA FILLERS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
• FIGURE 17 DERMA FILLERS MARKET: GEOGRAPHIC SNAPSHOT (2024)
• FIGURE 18 INCREASED AESTHETIC CONSCIOUSNESS AND RISING DISPOSABLE INCOME TO DRIVE MARKET
• FIGURE 19 SKIN REJUVENATION SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
• FIGURE 20 DERMATOLOGY CLINICS & HOSPITALS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
• FIGURE 21 CHINA TO REGISTER HIGHEST CAGR FROM 2025 TO 2030
• FIGURE 22 DERMA FILLERS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
• FIGURE 23 NEW REVENUE POCKETS FOR PLAYERS IN DERMA FILLERS MARKET
• FIGURE 24 AVERAGE SELLING PRICE TREND OF DERMA FILLER PRODUCTS, BY TYPE, 2022-2024 (USD)
• FIGURE 25 AVERAGE SELLING PRICE TREND OF HYALURONIC ACID FILLERS, BY KEY PLAYER, 2022-2024 (USD)
• FIGURE 26 AVERAGE SELLING PRICE TREND OF DERMA FILLER PRODUCTS, BY REGION, 2022-2024 (USD)
• FIGURE 27 DERMA FILLERS MARKET: VALUE CHAIN ANALYSIS
• FIGURE 28 DERMA FILLERS MARKET: SUPPLY CHAIN ANALYSIS
• FIGURE 29 DERMA FILLERS MARKET: ECOSYSTEM ANALYSIS
• FIGURE 30 INVESTMENT AND FUNDING SCENARIO, 2019-2023 (USD MILLION)
• FIGURE 31 NUMBER OF INVESTOR DEALS, BY KEY PLAYER, 2019-2023
• FIGURE 32 VALUE OF INVESTOR DEALS, BY KEY PLAYER, 2019-2023 (USD MILLION)
• FIGURE 33 DERMA FILLERS MARKET: PATENT ANALYSIS, 2014-2024
• FIGURE 34 DERMA FILLERS MARKET: IMPORT SCENARIO FOR HS CODE 330499, BY COUNTRY, 2020-2024 (USD THOUSAND)
• FIGURE 35 DERMA FILLERS MARKET: EXPORT SCENARIO FOR HS CODE 330499, BY COUNTRY, 2020-2024 (USD THOUSAND)
• FIGURE 36 DERMA FILLERS MARKET: PORTER'S FIVE FORCES ANALYSIS
• FIGURE 37 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF DERMA FILLERS, BY PRODUCT TYPE
• FIGURE 38 KEY BUYING CRITERIA FOR TOP THREE END USERS
• FIGURE 39 NORTH AMERICA: DERMA FILLERS MARKET SNAPSHOT
• FIGURE 40 ASIA PACIFIC: DERMA FILLERS MARKET SNAPSHOT
• FIGURE 41 REVENUE ANALYSIS OF KEY PLAYERS IN DERMA FILLERS MARKET, 2020-2024
• FIGURE 42 NATURAL DERMAL FILLERS MARKET SHARE ANALYSIS, 2024
• FIGURE 43 SYNTHETIC DERMA FILLERS MARKET SHARE ANALYSIS, 2024
• FIGURE 44 EV/EBITDA OF KEY VENDORS
• FIGURE 45 5-YEAR STOCK BETA OF KEY VENDORS
• FIGURE 46 DERMA FILLERS MARKET: BRAND/PRODUCT COMPARISON
• FIGURE 47 DERMA FILLERS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
• FIGURE 48 DERMA FILLERS MARKET: COMPANY FOOTPRINT
• FIGURE 49 DERMA FILLERS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
• FIGURE 50 ABBVIE INC.: COMPANY SNAPSHOT (2024)
• FIGURE 51 GALDERMA: COMPANY SNAPSHOT (2024)
• FIGURE 52 EVOLUS, INC.: COMPANY SNAPSHOT (2024)
• FIGURE 53 HUGEL, INC.: COMPANY SNAPSHOT (2024)
• FIGURE 54 MEDYTOX: COMPANY SNAPSHOT (2024)
• FIGURE 55 SCIVISION BIOTECH INC.: COMPANY SNAPSHOT (2024)
• FIGURE 56 ANIKA THERAPEUTICS, INC.: COMPANY SNAPSHOT (2024)

The derma fillers market is expected to experience significant growth, increasing from USD 4.1 billion in 2025 to USD 7.3 billion by 2030.

This growth is fueled by various factors, including demand for minimally invasive aesthetic procedures. Social media trends have normalized and mythologized the use of dermal fillers, particularly among Millennials and Generation Z. Plus, the prevalence of age-related skin issues, such as wrinkles and loss of volume, is stimulating the need for aesthetic treatments.

Fillers are being used for added indications (e.g., jawline, chin, hands) and the demand for customized treatments.

Continuous R&D and improved formulations (e.g., biodegradable and long-lasting injectables) and injection techniques have assured the long-term safety of fillers, making them even more appealing to practitioners and patients. These trends will continue to spur the growth of the global market.

"Natural dermal fillers dominated the market in 2024."

Natural dermal fillers, particularly those based on hyaluronic acid (HA), collagen, and other biodegradable, biocompatible materials, lead the market because they are highly biocompatible and have little risk of allergic reactions or side effects, all while being reversible as well. The worldwide trend toward less invasive aesthetic procedures for aesthetic improvements is a significant contributor to growth, whereby natural dermal fillers provide a non-surgical alternative for facial rejuvenation, wrinkle correction, and volume restoration. Natural dermal fillers are generation and consumer-driven, sourcing from consumer demand for safety, biocompatibility, and a natural-looking result, as well as consumer trends toward minimally invasive procedures, customizable treatments, and the popularity of social media and youth culture. Hyaluronic acid and other biodegradable fillers dominate natural dermal fillers and highlight consumer priorities, as natural fillers remain the preferred choice in the fast-growing derma fillers market.

"The dermatology clinics & hospitals segment held the largest share of the derma fillers market in 2024."

Dermatology clinics & hospitals are the primary end user in the derma fillers market, they are being fueled by increasing aesthetic demand with rising consumer interest in facial aesthetics and youthful appearance, product innovation, an expanding treatment indicator where clinics and hospitals are expanding their offerings to facial contouring, volume restoration, lip augmentation, or even hand rejuvenation, based on new product approvals and continuous patient needs. Other influences contributing to the performance, expertise, professional alliances and collaborations, and the socioeconomic environment have allowed procedures to be realized by patients and professionals alike. These drivers collectively provide domain and procedural growth and a lot of uptake in dermal filler procedures in both the clinics and hospital settings.

"The Asia Pacific region is expected to register the highest CAGR in the derma fillers market during the forecast period."

The Asia Pacific (APAC) region is one of the fastest emerging markets for dermal fillers, with growth driven by an unparalleled combination of demographic, economic, cultural, and technological factors. Demographic changes especially rising awareness and acceptance of aesthetic procedures (in particular among the younger and middle-aged consumer base), economic growth - resulting in a larger middle class with greater spending capacity, which makes non-invasive cosmetic skin treatment options accessible to a much wider audience, R&D and product releases of next-generation fillers which have significantly improved safety, efficacy and longevity, are all contributing factors leading to the growth of the APAC dermal fillers market. The exploding beauty consciousness, social media, continuous economic growth, aging populations, sustained innovation, medical tourism, supportive government policies, and developing healthcare infrastructures represent some of the major accelerators to the APAC dermal fillers market. The APAC derma fillers market is a large and very competitive market undergoing constant and rapid growth, driven by innovation.

A breakdown of the primary participants referred to for this report is provided below:

• By Company: Tier 1 (35%), Tier 2 (45%), and Tier 3 (20%)
• By Designation: C-level Executives (35%), Director-level Executives (25%), and Others (40%)
• By Region: North America (40%), Europe (30%), Asia Pacific (20%), Latin America (5%), and the Middle East & Africa (5%)

Prominent players in the derma fillers market include Allergan Aesthetics (US), Merz Pharma KGaA (Germany), Galderma (Switzerland), Sinclair Pharma (UK), Bioxis Pharmaceutical (France), Suneva Medical (US), Croma Pharma (Austria), Prollenium Medical Technologies (Canada), Dermax Med (China), Zimmer Aesthetics (Germany), Marllor Biomedical (Italy), MEDYTOX (South Korea), Revance Therapeutic (US), Dr. Korman Pharma (Israel), CGBio Co., Ltd. (South Korea), REGEN Biotech (UK), and BioScience GmbH (Germany), among others.

Research Coverage

• The report studies the derma fillers market based on brand, product, procedure, end user, and region.
• The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth.
• The report evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders.
• The report studies micro markets with respect to their growth trends, prospects, and contributions to the global derma fillers market.
• The report forecasts the revenue of market segments with respect to five major regions.

Key Benefits of Buying this Report

This report is valuable for both new and current players in the market, offering essential information to identify potential investment opportunities. It provides a comprehensive overview of both major and minor players, facilitating effective risk analysis and informed investment decisions. The report includes precise segmentation based on end users and geographical regions, offering detailed insights into niche market segments. Additionally, it highlights key trends, growth drivers, challenges, and opportunities, supporting strategic decision-making through a balanced analysis.

Through this report, readers get insightful views into the following parameters:

• Analysis of key drivers (Increasing demand for non-invasive aesthetic treatments, continued R&D has grown the sophistication of products, i.e., biodegradable longer-lasting fillers, improved injecting techniques), restraints (Cost barriers to treatment and the need for repeated treatments due to temporary nature of most derma fillers, concerns about adverse effects or complications can also impede market growth), opportunities (Exploration of biodegradable and bioresorbable fillers, potential for fillers to be used in conjunction with other aesthetic treatments, such as the use of botulinum toxin and laser therapy), challenges (the possibility of complications, such as vascular occlusion, granulomas or allergic reactions, can damage patient trust in procedures and also reputation and therefore negatively impact the market), relating to the growth of the derma fillers market.
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and product & service launches in the derma fillers market.
• Market Development: Comprehensive information about lucrative markets - the report analyzes the derma fillers market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the derma fillers market
• Competitive Assessment: A comprehensive analysis of market share, product offerings, and leading strategies of major players, such as Allergan Aesthetics (US), Merz Pharma KGaA (Germany), Galderma (Switzerland), Croma Pharma (Austria), Sinclair Pharma (UK), Bioxis Pharmaceutical (France), Suneva Medical (US), Prollenium Medical Technologies (Canada), Dermax Med (China), Zimmer Aesthetics (Germany), Marllor Biomedical (Italy), MEDYTOX (South Korea), Revance Therapeutic (US), Dr. Korman Pharma (Israel), CGBio Co., Ltd. (South Korea), REGEN Biotech (UK), and BioScience GmbH (Germany).

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKETS COVERED AND REGIONAL SCOPE
  • 1.3.2 INCLUSIONS AND EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
• 1.4 CURRENCY CONSIDERED
• 1.5 STAKEHOLDERS

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY RESEARCH
    • 2.1.1.1 Key secondary sources
    • 2.1.1.2 Key data from secondary sources
    • 2.1.1.3 Objectives of secondary research
• 2.2 MARKET SIZE ESTIMATION
  • 2.2.1 BOTTOM-UP APPROACH
    • 2.2.1.1 Approach 1: Company revenue estimation
    • 2.2.1.2 Approach 2: Customer-based market estimation
    • 2.2.1.3 Approach 3: Primary interviews
  • 2.2.2 TOP-DOWN APPROACH
• 2.3 GROWTH FORECAST
• 2.4 DATA TRIANGULATION
• 2.5 RESEARCH ASSUMPTIONS
• 2.6 RESEARCH LIMITATIONS
• 2.7 RISK ANALYSIS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 DERMA FILLERS MARKET OVERVIEW
• 4.2 NORTH AMERICA: DERMA FILLERS MARKET, BY PROCEDURE, 2025 VS. 2030 (USD MILLION)
• 4.3 EUROPE: DERMA FILLERS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
• 4.4 DERMA FILLERS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Increasing adoption of minimally invasive and non-invasive aesthetic procedures
    • 5.2.1.2 Growing demand for aesthetic treatments among elderly and men
    • 5.2.1.3 Rising acceptance and normalization of fillers among millennials and Gen Z fueled by social media
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 Risk of infection and safety concerns
    • 5.2.2.2 Complex regulatory framework and compliance standards
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Growth opportunities in emerging markets
    • 5.2.3.2 Launch of new technologies and products
  • 5.2.4 CHALLENGES
    • 5.2.4.1 High cost of treatments and devices
    • 5.2.4.2 Social and cultural barriers
• 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
• 5.4 PRICING ANALYSIS
  • 5.4.1 AVERAGE SELLING PRICE TREND, BY PRODUCT
  • 5.4.2 AVERAGE SELLING PRICE TREND, BY KEY PLAYER
  • 5.4.3 AVERAGE SELLING PRICE TREND, BY REGION
• 5.5 VALUE CHAIN ANALYSIS
  • 5.5.1 RESEARCH & DEVELOPMENT
  • 5.5.2 RAW MATERIAL PROCUREMENT AND PRODUCT MANUFACTURING
  • 5.5.3 DISTRIBUTION, MARKETING & SALES, AND AFTER-SALES SERVICES
• 5.6 SUPPLY CHAIN ANALYSIS
  • 5.6.1 PROMINENT COMPANIES
  • 5.6.2 SMALL AND MEDIUM-SIZED ENTERPRISES
  • 5.6.3 END USERS
• 5.7 ECOSYSTEM ANALYSIS
• 5.8 INVESTMENT AND FUNDING SCENARIO
• 5.9 TECHNOLOGY ANALYSIS
  • 5.9.1 KEY TECHNOLOGIES
    • 5.9.1.1 Advanced Hyaluronic Acid (HA) cross-linking
    • 5.9.1.2 Polymethylmethacrylate (PMMA) fillers
    • 5.9.1.3 Bio-stimulatory fillers
  • 5.9.2 COMPLEMENTARY TECHNOLOGIES
    • 5.9.2.1 Laser resurfacing
    • 5.9.2.2 Microneedling
  • 5.9.3 ADJACENT TECHNOLOGIES
    • 5.9.3.1 3D imaging and AI-based facial mapping
• 5.10 PATENT ANALYSIS
• 5.11 TRADE ANALYSIS
  • 5.11.1 IMPORT SCENARIO (HS CODE 330499)
  • 5.11.2 EXPORT SCENARIO (HS CODE 330499)
• 5.12 KEY CONFERENCES AND EVENTS, 2025-2026
• 5.13 CASE STUDY ANALYSIS
  • 5.13.1 COMMERCIAL PARTNERSHIPS FOR AESTHETIC PRODUCT SALES
  • 5.13.2 DIVERSIFICATION OF BUSINESS TO MEET CUSTOMER DEMANDS
  • 5.13.3 COLLABORATIONS WITH SMES FOR STREAMLINING LASER-BASED DEVICES
• 5.14 REGULATORY LANDSCAPE
  • 5.14.1 REGULATORY ANALYSIS
    • 5.14.1.1 North America
      • 5.14.1.1.1 US
      • 5.14.1.1.2 Canada
    • 5.14.1.2 Europe
      • 5.14.1.2.1 UK
      • 5.14.1.2.2 France
      • 5.14.1.2.3 Germany
    • 5.14.1.3 Asia Pacific
      • 5.14.1.3.1 Japan
      • 5.14.1.3.2 India
    • 5.14.1.4 Rest of the World
      • 5.14.1.4.1 Brazil
      • 5.14.1.4.2 UAE
  • 5.14.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• 5.15 PORTER'S FIVE FORCES ANALYSIS
  • 5.15.1 BARGAINING POWER OF SUPPLIERS
  • 5.15.2 BARGAINING POWER OF BUYERS
  • 5.15.3 THREAT OF NEW ENTRANTS
  • 5.15.4 THREAT OF SUBSTITUTES
  • 5.15.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.16 KEY STAKEHOLDERS AND BUYING CRITERIA
  • 5.16.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.16.2 BUYING CRITERIA
• 5.17 REIMBURSEMENT SCENARIO
• 5.18 UNMET NEEDS AND KEY PAIN POINTS
• 5.19 IMPACT OF AI ON DERMA FILLERS MARKET
  • 5.19.1 INTRODUCTION
  • 5.19.2 MARKET POTENTIAL OF AI ON DERMA FILLERS ECOSYSTEM
  • 5.19.3 AI USE CASES
  • 5.19.4 KEY COMPANIES IMPLEMENTING AI
  • 5.19.5 FUTURE OF GENERATIVE AI IN DERMA FILLERS MARKET
• 5.20 US TARIFF 2025
  • 5.20.1 INTRODUCTION
  • 5.20.2 KEY TARIFF RATES
  • 5.20.3 PRICE IMPACT ANALYSIS
  • 5.20.4 IMPACT ON COUNTRY/REGION
    • 5.20.4.1 US
    • 5.20.4.2 Europe
    • 5.20.4.3 Asia Pacific
  • 5.20.5 IMPACT ON END-USE INDUSTRIES

6 DERMA FILLERS MARKET, BY BRAND

• 6.1 INTRODUCTION
• 6.2 JUVEDERM
  • 6.2.1 WIDE INDICATION COVERAGE AND GLOBAL REACH TO CONTRIBUTE TO GROWTH
• 6.3 RESTYLANE
  • 6.3.1 FASTER ONSET DURATION AND LONG-LASTING EFFECT TO ENCOURAGE GROWTH
• 6.4 RHA COLLECTION
  • 6.4.1 GROWING DESIRE FOR NATURAL EXPRESSIONS TO BOOST MARKET
• 6.5 SCULPTRA
  • 6.5.1 INCREASED ADOPTION OF SCULPTRA AMONG ADVANCED INJECTORS TO BOLSTER GROWTH
• 6.6 RADIESSE
  • 6.6.1 STABLE SUCCESS RATES AND DESIRED RESULTS TO SPUR GROWTH
• 6.7 LANLUMA
  • 6.7.1 EXPANDED USE CASES IN BODY CONTOURING APPLICATIONS TO INTENSIFY GROWTH
• 6.8 BELLAFILL
  • 6.8.1 USE OF BELLAFILL FOR TREATING DEEP ACNE SCARS AND NASOLABIAL FOLDS TO FOSTER GROWTH
• 6.9 OTHER BRANDS

7 DERMA FILLERS MARKET, BY PRODUCT TYPE

• 7.1 INTRODUCTION
• 7.2 NATURAL DERMAL FILLERS
  • 7.2.1 HYALURONIC ACID FILLERS
    • 7.2.1.1 Wide clinical acceptance and safety profile to aid growth
  • 7.2.2 COLLAGEN FILLERS
    • 7.2.2.1 Ability to provide structural support and improved skin texture to boost market
• 7.3 SYNTHETIC DERMAL FILLERS
  • 7.3.1 CALCIUM HYDROXYLAPATITE (CAHA) FILLERS
    • 7.3.1.1 Long-term collagen stimulation property to augment growth
  • 7.3.2 POLY-L-LACTIC ACID (PLLA) FILLERS
    • 7.3.2.1 Increasing desire for natural, progressive rejuvenation to stimulate growth
  • 7.3.3 POLYMETHYL METHACRYLATE (PMMA) FILLERS
    • 7.3.3.1 Long-lasting structural correction ability to favor growth
  • 7.3.4 POLYNUCLEOTIDE FILLERS
    • 7.3.4.1 Rising preference for skin revitalization procedures to fuel market
  • 7.3.5 OTHER SYNTHETIC FILLERS

8 DERMA FILLERS MARKET, BY PROCEDURE

• 8.1 INTRODUCTION
• 8.2 SKIN REJUVENATION
  • 8.2.1 INCREASING ACCEPTANCE AND REPEATABILITY OF SKIN PROCEDURES TO FACILITATE GROWTH
• 8.3 FACE & BODY CONTOURING
  • 8.3.1 RISING NUMBER OF FACIAL AND BODY CONTOURING-RELATED PROCEDURES TO PROMOTE GROWTH
• 8.4 LIP AUGMENTATION
  • 8.4.1 NEED FOR REPETITIVE CYCLES TO MAINTAIN DESIRED LOOK TO PROPEL MARKET
• 8.5 OTHER PROCEDURES

9 DERMA FILLERS MARKET, BY END USER

• 9.1 INTRODUCTION
• 9.2 DERMATOLOGY CLINICS & HOSPITALS
  • 9.2.1 RISING TREND OF MEDICAL TOURISM AND PLASTIC SURGERY TO SUPPORT GROWTH
• 9.3 BEAUTY CENTERS
  • 9.3.1 GROWING INCLINATION TOWARD CUSTOMIZED TREATMENT TO DRIVE MARKET
• 9.4 MEDICAL SPAS
  • 9.4.1 INCREASING FOCUS ON CONVENIENCE, TREATMENT FLEXIBILITY, AND COST SAVING TO SPUR GROWTH
• 9.5 OTHER END USERS

10 DERMA FILLERS MARKET, BY REGION

• 10.1 INTRODUCTION
• 10.2 NORTH AMERICA
  • 10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 10.2.2 US
    • 10.2.2.1 Rising geriatric population to spur growth
  • 10.2.3 CANADA
    • 10.2.3.1 Preference of aging individuals to reduce aging signs to promote growth
• 10.3 EUROPE
  • 10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 10.3.2 GERMANY
    • 10.3.2.1 Large consumer base to expedite growth
  • 10.3.3 UK
    • 10.3.3.1 Increasing volume-enhancement treatments to support growth
  • 10.3.4 FRANCE
    • 10.3.4.1 Favorable demographics and increased acceptance of non-surgical procedures to aid growth
  • 10.3.5 ITALY
    • 10.3.5.1 Growing acceptance of minimally invasive procedures to fuel market
  • 10.3.6 SPAIN
    • 10.3.6.1 Increasing availability of safe and minimally invasive treatments to augment growth
  • 10.3.7 REST OF EUROPE
• 10.4 ASIA PACIFIC
  • 10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 10.4.2 JAPAN
    • 10.4.2.1 Growing trend of volume restoration and wrinkle correction to boost market
  • 10.4.3 CHINA
    • 10.4.3.1 Surging demand for aesthetic procedures to accelerate growth
  • 10.4.4 INDIA
    • 10.4.4.1 Rapid urbanization and proliferation of clinics to stimulate growth
  • 10.4.5 AUSTRALIA
    • 10.4.5.1 Rising safety standards for non-surgical cosmetic procedures to encourage growth
  • 10.4.6 SOUTH KOREA
    • 10.4.6.1 Robust medical infrastructure to speed up growth
  • 10.4.7 REST OF ASIA PACIFIC
• 10.5 LATIN AMERICA
  • 10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 10.5.2 BRAZIL
    • 10.5.2.1 Cultural normalization of aesthetic treatments to contribute to growth
  • 10.5.3 MEXICO
    • 10.5.3.1 Increasing inflow of medical tourists to sustain growth
  • 10.5.4 REST OF LATIN AMERICA
• 10.6 MIDDLE EAST & AFRICA
  • 10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 10.6.2 GCC COUNTRIES
    • 10.6.2.1 Booming aesthetic tourism sector to facilitate growth
  • 10.6.3 REST OF MIDDLE EAST & AFRICA

11 COMPETITIVE LANDSCAPE

• 11.1 INTRODUCTION
• 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
• 11.3 REVENUE ANALYSIS, 2020-2024
• 11.4 MARKET SHARE ANALYSIS, 2024
  • 11.4.1 NATURAL DERMA FILLERS MARKET SHARE
  • 11.4.2 SYNTHETIC DERMAL FILLERS MARKET SHARE
• 11.5 COMPANY VALUATION AND FINANCIAL METRICS
• 11.6 BRAND/PRODUCT COMPARISON
• 11.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
  • 11.7.1 STARS
  • 11.7.2 EMERGING LEADERS
  • 11.7.3 PERVASIVE PLAYERS
  • 11.7.4 PARTICIPANTS
  • 11.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
    • 11.7.5.1 Company footprint
    • 11.7.5.2 Region footprint
    • 11.7.5.3 Product type footprint
    • 11.7.5.4 Procedure footprint
    • 11.7.5.5 End-user footprint
• 11.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
  • 11.8.1 PROGRESSIVE COMPANIES
  • 11.8.2 RESPONSIVE COMPANIES
  • 11.8.3 DYNAMIC COMPANIES
  • 11.8.4 STARTING BLOCKS
  • 11.8.5 COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
    • 11.8.5.1 Detailed list of key startups/SMEs
    • 11.8.5.2 Competitive benchmarking of key startups/SMEs
• 11.9 COMPETITIVE SCENARIO
  • 11.9.1 PRODUCT LAUNCHES AND APPROVALS
  • 11.9.2 DEALS

12 COMPANY PROFILES

• 12.1 KEY PLAYERS
  • 12.1.1 ABBVIE INC.
    • 12.1.1.1 Business overview
    • 12.1.1.2 Products offered
    • 12.1.1.3 Recent developments
      • 12.1.1.3.1 Product launches and approvals
    • 12.1.1.4 MnM view
      • 12.1.1.4.1 Key strengths
      • 12.1.1.4.2 Strategic choices
      • 12.1.1.4.3 Weaknesses and competitive threats
  • 12.1.2 GALDERMA
    • 12.1.2.1 Business overview
    • 12.1.2.2 Products offered
    • 12.1.2.3 Recent developments
      • 12.1.2.3.1 Product launches and approvals
      • 12.1.2.3.2 Deals
      • 12.1.2.3.3 Expansions
    • 12.1.2.4 MnM view
      • 12.1.2.4.1 Key strengths
      • 12.1.2.4.2 Strategic choices
      • 12.1.2.4.3 Weaknesses and competitive threats
  • 12.1.3 MERZ PHARMA
    • 12.1.3.1 Business overview
    • 12.1.3.2 Products offered
    • 12.1.3.3 Recent developments
      • 12.1.3.3.1 Expansions
    • 12.1.3.4 MnM view
      • 12.1.3.4.1 Key strengths
      • 12.1.3.4.2 Strategic choices
      • 12.1.3.4.3 Weaknesses and competitive threats
  • 12.1.4 SILCLAIR PHARMA
    • 12.1.4.1 Business overview
    • 12.1.4.2 Products offered
    • 12.1.4.3 MnM view
      • 12.1.4.3.1 Key strengths
      • 12.1.4.3.2 Strategic choices
      • 12.1.4.3.3 Weaknesses and competitive threats
  • 12.1.5 REVANCE
    • 12.1.5.1 Business overview
    • 12.1.5.2 Products offered
    • 12.1.5.3 Recent developments
      • 12.1.5.3.1 Product launches and approvals
      • 12.1.5.3.2 Deals
    • 12.1.5.4 MnM view
      • 12.1.5.4.1 Key strengths
      • 12.1.5.4.2 Strategic choices
      • 12.1.5.4.3 Weaknesses and competitive threats
  • 12.1.6 CROMA PHARMA
    • 12.1.6.1 Business overview
    • 12.1.6.2 Products offered
  • 12.1.7 EVOLUS, INC.
    • 12.1.7.1 Business overview
    • 12.1.7.2 Products offered
    • 12.1.7.3 Recent developments
      • 12.1.7.3.1 Product launches and approvals
  • 12.1.8 HUGEL, INC.
    • 12.1.8.1 Business overview
    • 12.1.8.2 Products offered
  • 12.1.9 MEDYTOX
    • 12.1.9.1 Business overview
    • 12.1.9.2 Products offered
  • 12.1.10 BIOXIS PHARMACEUTICAL
    • 12.1.10.1 Business overview
    • 12.1.10.2 Products offered
  • 12.1.11 ZIMMER MEDIZINSYSTEME GMBH
    • 12.1.11.1 Business overview
    • 12.1.11.2 Products offered
  • 12.1.12 CUTERA, INC.
    • 12.1.12.1 Business overview
    • 12.1.12.2 Products offered
    • 12.1.12.3 Recent developments
      • 12.1.12.3.1 Product launches and approvals
      • 12.1.12.3.2 Deals
  • 12.1.13 SCIVISION BIOTECH INC.
    • 12.1.13.1 Business overview
    • 12.1.13.2 Products offered
  • 12.1.14 BRIDGEPOINT GROUP PLC
    • 12.1.14.1 Business overview
    • 12.1.14.2 Products offered
  • 12.1.15 ANIKA THERAPEUTICS, INC.
    • 12.1.15.1 Business overview
    • 12.1.15.2 Products offered
• 12.2 OTHER PLAYERS
  • 12.2.1 TIGER AESTHETICS MEDICAL
  • 12.2.2 PROLLENIUM MEDICAL TECHNOLOGIES
  • 12.2.3 BIOSCIENCE GMBH
  • 12.2.4 DERMAX
  • 12.2.5 TEOXANE
  • 12.2.6 DR. KORMAN LABORATORIES LTD.
  • 12.2.7 CYTOPHIL, INC.
  • 12.2.8 TELETA PHARMA
  • 12.2.9 IBSA DERMA
  • 12.2.10 NEOGENESIS
  • 12.2.11 CGBIO, CO., LTD.

13 APPENDIX

• 13.1 DISCUSSION GUIDE
• 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 13.3 CUSTOMIZATION OPTIONS
• 13.4 RELATED REPORTS
• 13.5 AUTHOR DETAILS